Nuvation Bio
NUVB
NUVB
121 hedge funds and large institutions have $318M invested in Nuvation Bio in 2022 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 42 increasing their positions, 28 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
6.24% less ownership
Funds ownership: 71.5% → 65.26% (-6.2%)
37% less capital invested
Capital invested by funds: $503M → $318M (-$186M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $23K
Holders
121
Holding in Top 10
3
Calls
–
Puts
$23K
Top Buyers
| 1 | +$1.85M | |
| 2 | +$1.82M | |
| 3 | +$895K | |
| 4 |
CCM
CAAS Capital Management
New York
|
+$863K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$605K |
Top Sellers
| 1 | -$15.7M | |
| 2 | -$14.1M | |
| 3 | -$5.73M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$4.81M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.56M |